previous REGIONAL & GLOBAL THOUGHT LEADERS AT EMERGE 2050

Emerge 2050 speakers are leading industry visionaries at the sharp edge of where health and technology are converging.

The two-day conference and networking event will be presented by the leading names in Capital Investment in health-tech innovation internationally, supported by tech innovators, many of whom have gone on to achieve US$ multi-million valuations, or so-called unicorn status, with a ticket price of US$1billion plus.

Ahmed Al-Bader

Co-Founder & CEO, SihaTech.com

Obediah Ayton

Director, Dhabi Hold Co

Mussaad Al Razouki

Chief Investment & BDO, Kuwait Life Sciences Company

Viktoriya Vasilenko

Founder & CEO, Knowledge Gate Group

Abhishek Shah

Founder & CEO,
Wellthy Therapeutics

Ihsan Jawad

General Partner,
STV

Mohamed Gamal

Group Information Technology Director, United Eastern Medical Services (UEMedical)

Edward Kliphuis

Partner, Sofinnova Partners

Cesare Magri

Founder,
4BetterDevices GmbH

Mark Krul

Founder,
Aglaia Management B.V.

Unmesh Lal

Global Director – Healthcare & Life Sciences Frost & Sullivan

Hakan Esin

Director,
Diginova Health Solutions

Dr. Sarper Tanli

Managing Director MEA
Mass General Brigham

Yoram Wijngaarde

Founder and CEO, Dealroom.co

Jeffrey A. Stephens

General Partner,
Infusion 51a

Filippo Castiglione

Executive Director,
Technology Innovation Institute

Ayoub Glia

Postdoctoral Research Associate,
Celltiro

Faisal A. AlHusry

Principal,
Hikma Ventures

Sophie Smith

Founder and CEO, Nabta Health

Dr. Sadyk Gusniev

Health Tech Expert & Researcher

Clara Roche

Manager – Health Policy & Insights, Economist Impact

Panos Lioulias

Founder, Uni.Fund

Dr Glen Hagemann

Director, Mediclinic Middle East

Diego Palacio

Chief Commercial Officer, Coat Connect

The two-day conference and networking event will be presented by the leading names in capital Investment in health-tech innovation internationally, supported by tech innovators, many of whom have gone on to achieve US$ multi-million valuations, or so-called unicorn status, with a ticket price of US$1billion plus.